Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis
每周一次厄洛替尼给药以减少家族性腺瘤性息肉病相关十二指肠息肉负荷的II期试验
期刊:Gut
影响因子:25.8
doi:10.1136/gutjnl-2021-326532
Samadder, N Jewel; Foster, Nathan; McMurray, Ryan P; Burke, Carol A; Stoffel, Elena; Kanth, Priyanka; Das, Rohit; Cruz-Correa, Marcia; Vilar, E; Mankaney, Gautam; Buttar, Navtej; Thirumurthi, Selvi; Turgeon, Danielle K; Sossenheimer, Michael; Westover, Michelle; Richmond, Ellen; Umar, Asad; Della'Zanna, Gary; Rodriguez, Luz M; Szabo, Eva; Zahrieh, David; Limburg, Paul J